MINIREVIEWS

1. Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers
2. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis

ORIGINAL ARTICLE

1. Transcriptional factor III A promotes colorectal cancer progression by upregulating cystatin A
2. VCAN,expressed highly in hepatitis B virus-induced hepatocellular carcinoma,is a potential biomarker for immune checkpoint inhibitors
3. Overexpression of ELL-associated factor 2 suppresses invasion,migration,and angiogenesis in colorectal cancer
4. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells
5. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
6. Multi-slice spiral computed tomography in differential diagnosis of gastric stromal tumors and benign gastric polyps,and gastric stromal tumor risk stratification assessment
7. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy
8. Role of sex on psychological distress,quality of life,and coping of patients with advanced colorectal and non-colorectal cancer
9. Droplet digital polymerase chain reaction assay for methylated ring finger protein 180 in gastric cancer
10. Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study
11. Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis”

META-ANALYSIS

1. Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis

CASE REPORT

1. Disseminated carcinomatosis of the bone marrow caused by granulocyte colony-stimulating factor: A case report and review of literature